Welcome to our dedicated page for KT&G GDR 144A news (Ticker: KTCIY), a resource for investors and traders seeking the latest updates and insights on KT&G GDR 144A stock.
KT&G Corporation (KRX:033780), known for its tobacco, ginseng, and herbal products, has recently faced an ISS recommendation to vote against its Board of Directors' proposals. KT&G expressed concerns about ISS' reliance on data provided by dissident shareholder Flashlight Capital Partners, impacting overseas business performance analysis. Additionally, ISS' recommendations against CEO nominee Kyung-man Bang and other candidates raise questions on CEO selection impartiality and Board-endorsed Outside Candidate director candidacy. KT&G emphasizes rigorous CEO selection processes and inconsistencies between ISS' recommendations and its proxy voting guidelines. Furthermore, discussions between ISS, FCP, and KT&G raised concerns over export business profitability data discrepancies, misinformation, and interactions. KT&G seeks to engage constructively with stakeholders, address concerns, and ensure shareholder value.
Korea Ginseng held an international seminar at the International Conference on the Science of Botanicals (ICSB) about Korean red ginseng in the U.S. The seminar showcased scientific research on the safety, efficacy, and neuroprotective insights of Korean red ginseng. Key speakers included experts from Taiwan, the U.S., and Korea, presenting results of studies confirming the benefits of Korean red ginseng. The seminar highlighted the safety of red ginseng as a food ingredient and dietary supplement, emphasizing its role in improving circulation, immunity, and cognitive function. KGCUS plans to continue scientific research and develop customized products for the U.S. market, aiming to promote the excellence of Korean red ginseng to American consumers.